Multimedia content is supported by an unrestricted educational grant from:

Scientific Agenda

Session VII: Management of fungal infections III: The future of antifungal therapy?
Moderator: William Dismukes, MD

Mould active azoles: Interaction with immunomodulators and anti-cancer agents, comparative pharmacokinetics/dynamics to include CNS penetration, food effect, IV/PO
Paul O. Gubbins, PharmD

Echinocandins: Comparative pharmacokinetics/dynamics of caspofungin, micafungin and anidulafungin with implications for trial design and patient care
Thomas J. Walsh, MD

Polyenes: “Do the old dogs have new tricks?"
John R. Graybill, MD